nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—PTGS1—Diphenhydramine—atopic dermatitis	0.076	0.0984	CbGbCtD
Dronabinol—CYP2A6—Prednisolone—atopic dermatitis	0.0522	0.0676	CbGbCtD
Dronabinol—ABCG2—Hydrocortisone—atopic dermatitis	0.0458	0.0593	CbGbCtD
Dronabinol—CYP3A4—Pimecrolimus—atopic dermatitis	0.0409	0.0529	CbGbCtD
Dronabinol—ABCB1—Tacrolimus—atopic dermatitis	0.0405	0.0525	CbGbCtD
Dronabinol—CYP2C19—Loratadine—atopic dermatitis	0.0368	0.0476	CbGbCtD
Dronabinol—CYP2C19—Diphenhydramine—atopic dermatitis	0.0368	0.0476	CbGbCtD
Dronabinol—CYP2A6—Dexamethasone—atopic dermatitis	0.0308	0.0398	CbGbCtD
Dronabinol—CYP2C9—Loratadine—atopic dermatitis	0.0306	0.0396	CbGbCtD
Dronabinol—CYP2C9—Diphenhydramine—atopic dermatitis	0.0306	0.0396	CbGbCtD
Dronabinol—ABCB1—Loratadine—atopic dermatitis	0.0297	0.0384	CbGbCtD
Dronabinol—ABCG2—Dexamethasone—atopic dermatitis	0.0285	0.0369	CbGbCtD
Dronabinol—ABCB1—Methylprednisolone—atopic dermatitis	0.0271	0.0352	CbGbCtD
Dronabinol—CYP1A1—Dexamethasone—atopic dermatitis	0.0263	0.034	CbGbCtD
Dronabinol—CYP3A4—Tacrolimus—atopic dermatitis	0.0243	0.0315	CbGbCtD
Dronabinol—CYP2C19—Prednisone—atopic dermatitis	0.0204	0.0264	CbGbCtD
Dronabinol—CYP3A4—Loratadine—atopic dermatitis	0.0178	0.023	CbGbCtD
Dronabinol—ABCB1—Betamethasone—atopic dermatitis	0.0176	0.0229	CbGbCtD
Dronabinol—ABCB1—Prednisolone—atopic dermatitis	0.0174	0.0226	CbGbCtD
Dronabinol—ABCB1—Hydrocortisone—atopic dermatitis	0.0165	0.0214	CbGbCtD
Dronabinol—ABCB1—Prednisone—atopic dermatitis	0.0164	0.0213	CbGbCtD
Dronabinol—CYP3A4—Methylprednisolone—atopic dermatitis	0.0163	0.0211	CbGbCtD
Dronabinol—CYP2C19—Dexamethasone—atopic dermatitis	0.0127	0.0165	CbGbCtD
Dronabinol—CYP3A4—Triamcinolone—atopic dermatitis	0.0123	0.016	CbGbCtD
Dronabinol—CYP2C9—Dexamethasone—atopic dermatitis	0.0106	0.0137	CbGbCtD
Dronabinol—CYP3A4—Betamethasone—atopic dermatitis	0.0106	0.0137	CbGbCtD
Dronabinol—CYP3A4—Prednisolone—atopic dermatitis	0.0104	0.0135	CbGbCtD
Dronabinol—ABCB1—Dexamethasone—atopic dermatitis	0.0103	0.0133	CbGbCtD
Dronabinol—CYP3A4—Hydrocortisone—atopic dermatitis	0.00989	0.0128	CbGbCtD
Dronabinol—CYP3A4—Prednisone—atopic dermatitis	0.00985	0.0128	CbGbCtD
Dronabinol—CYP3A4—Dexamethasone—atopic dermatitis	0.00615	0.00797	CbGbCtD
Dronabinol—CNR2—G alpha (i) signalling events—CCL27—atopic dermatitis	0.000934	0.0209	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000833	0.0186	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Other—CXCR3—atopic dermatitis	0.000806	0.018	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000742	0.0166	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—CCL27—atopic dermatitis	0.000733	0.0164	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000666	0.0149	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000654	0.0146	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CCL22—atopic dermatitis	0.000634	0.0142	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000583	0.013	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CCL27—atopic dermatitis	0.000565	0.0126	CbGpPWpGaD
Dronabinol—CNR1—N-cadherin signaling events—MAPK8—atopic dermatitis	0.000564	0.0126	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00055	0.0123	CbGpPWpGaD
Dronabinol—Dizziness—Dimenhydrinate—atopic dermatitis	0.000539	0.00294	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000537	0.012	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000523	0.0117	CbGpPWpGaD
Dronabinol—Feeling abnormal—Loratadine—atopic dermatitis	0.000517	0.00282	CcSEcCtD
Dronabinol—Tension—Tacrolimus—atopic dermatitis	0.000515	0.00281	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000514	0.0028	CcSEcCtD
Dronabinol—Rash—Diphenhydramine—atopic dermatitis	0.000514	0.0028	CcSEcCtD
Dronabinol—Rash—Dimenhydrinate—atopic dermatitis	0.000514	0.0028	CcSEcCtD
Dronabinol—Anorexia—Mometasone—atopic dermatitis	0.000513	0.0028	CcSEcCtD
Dronabinol—Dermatitis—Diphenhydramine—atopic dermatitis	0.000513	0.0028	CcSEcCtD
Dronabinol—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000513	0.0028	CcSEcCtD
Dronabinol—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000513	0.0028	CcSEcCtD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000511	0.0114	CbGpPWpGaD
Dronabinol—Headache—Diphenhydramine—atopic dermatitis	0.00051	0.00279	CcSEcCtD
Dronabinol—Headache—Dimenhydrinate—atopic dermatitis	0.00051	0.00279	CcSEcCtD
Dronabinol—Nervousness—Tacrolimus—atopic dermatitis	0.00051	0.00278	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CCL17—atopic dermatitis	0.000507	0.0113	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Other—CCR5—atopic dermatitis	0.000505	0.0113	CbGpPWpGaD
Dronabinol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.0005	0.0112	CbGpPWpGaD
Dronabinol—CYP1A1—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000498	0.0111	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCL22—atopic dermatitis	0.000498	0.0111	CbGpPWpGaD
Dronabinol—Rash—Pimecrolimus—atopic dermatitis	0.000497	0.00271	CcSEcCtD
Dronabinol—Dermatitis—Pimecrolimus—atopic dermatitis	0.000496	0.00271	CcSEcCtD
Dronabinol—Abdominal pain—Loratadine—atopic dermatitis	0.000496	0.00271	CcSEcCtD
Dronabinol—Headache—Pimecrolimus—atopic dermatitis	0.000494	0.00269	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000491	0.00268	CcSEcCtD
Dronabinol—Ill-defined disorder—Tacrolimus—atopic dermatitis	0.000487	0.00266	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000481	0.0108	CbGpPWpGaD
Dronabinol—Euphoric mood—Prednisone—atopic dermatitis	0.000479	0.00261	CcSEcCtD
Dronabinol—Malaise—Tacrolimus—atopic dermatitis	0.000474	0.00258	CcSEcCtD
Dronabinol—Decreased appetite—Mometasone—atopic dermatitis	0.000468	0.00255	CcSEcCtD
Dronabinol—Fatigue—Mometasone—atopic dermatitis	0.000464	0.00253	CcSEcCtD
Dronabinol—Palpitations—Tacrolimus—atopic dermatitis	0.000464	0.00253	CcSEcCtD
Dronabinol—Cough—Tacrolimus—atopic dermatitis	0.000458	0.0025	CcSEcCtD
Dronabinol—Convulsion—Tacrolimus—atopic dermatitis	0.000455	0.00248	CcSEcCtD
Dronabinol—Asthenia—Loratadine—atopic dermatitis	0.00045	0.00246	CcSEcCtD
Dronabinol—Myalgia—Tacrolimus—atopic dermatitis	0.000447	0.00244	CcSEcCtD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000446	0.00999	CbGpPWpGaD
Dronabinol—Anxiety—Tacrolimus—atopic dermatitis	0.000446	0.00243	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000444	0.00242	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000444	0.00992	CbGpPWpGaD
Dronabinol—Discomfort—Tacrolimus—atopic dermatitis	0.000442	0.00241	CcSEcCtD
Dronabinol—Gastrointestinal pain—Mometasone—atopic dermatitis	0.00044	0.0024	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000438	0.00979	CbGpPWpGaD
Dronabinol—Dry mouth—Tacrolimus—atopic dermatitis	0.000437	0.00239	CcSEcCtD
Dronabinol—Confusional state—Tacrolimus—atopic dermatitis	0.000432	0.00236	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000432	0.00966	CbGpPWpGaD
Dronabinol—Amnesia—Prednisone—atopic dermatitis	0.000431	0.00235	CcSEcCtD
Dronabinol—Diarrhoea—Loratadine—atopic dermatitis	0.000429	0.00234	CcSEcCtD
Dronabinol—Abdominal pain—Mometasone—atopic dermatitis	0.000426	0.00232	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000421	0.00942	CbGpPWpGaD
Dronabinol—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00042	0.00229	CcSEcCtD
Dronabinol—Tachycardia—Tacrolimus—atopic dermatitis	0.000418	0.00228	CcSEcCtD
Dronabinol—Conjunctivitis—Prednisolone—atopic dermatitis	0.000417	0.00228	CcSEcCtD
Dronabinol—Skin disorder—Tacrolimus—atopic dermatitis	0.000416	0.00227	CcSEcCtD
Dronabinol—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000415	0.00227	CcSEcCtD
Dronabinol—Dizziness—Loratadine—atopic dermatitis	0.000415	0.00226	CcSEcCtD
Dronabinol—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000414	0.00226	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CCL11—atopic dermatitis	0.000409	0.00914	CbGpPWpGaD
Dronabinol—Anorexia—Tacrolimus—atopic dermatitis	0.000409	0.00223	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—BDNF—atopic dermatitis	0.000405	0.00907	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000401	0.00896	CbGpPWpGaD
Dronabinol—Hypotension—Tacrolimus—atopic dermatitis	0.0004	0.00219	CcSEcCtD
Dronabinol—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000399	0.00218	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000398	0.0089	CbGpPWpGaD
Dronabinol—Rash—Loratadine—atopic dermatitis	0.000396	0.00216	CcSEcCtD
Dronabinol—Dermatitis—Loratadine—atopic dermatitis	0.000395	0.00216	CcSEcCtD
Dronabinol—Headache—Loratadine—atopic dermatitis	0.000393	0.00215	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.00039	0.00213	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00039	0.00872	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00039	0.00872	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000389	0.0087	CbGpPWpGaD
Dronabinol—Asthenia—Mometasone—atopic dermatitis	0.000386	0.00211	CcSEcCtD
Dronabinol—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000386	0.00211	CcSEcCtD
Dronabinol—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000384	0.00209	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000382	0.00856	CbGpPWpGaD
Dronabinol—Somnolence—Tacrolimus—atopic dermatitis	0.000381	0.00208	CcSEcCtD
Dronabinol—Pruritus—Mometasone—atopic dermatitis	0.000381	0.00208	CcSEcCtD
Dronabinol—Sweating—Methylprednisolone—atopic dermatitis	0.000378	0.00206	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000377	0.00844	CbGpPWpGaD
Dronabinol—Hallucination—Hydrocortisone—atopic dermatitis	0.000374	0.00204	CcSEcCtD
Dronabinol—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000373	0.00204	CcSEcCtD
Dronabinol—Decreased appetite—Tacrolimus—atopic dermatitis	0.000373	0.00203	CcSEcCtD
Dronabinol—Fatigue—Tacrolimus—atopic dermatitis	0.00037	0.00202	CcSEcCtD
Dronabinol—Diarrhoea—Mometasone—atopic dermatitis	0.000368	0.00201	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—NGF—atopic dermatitis	0.00036	0.00805	CbGpPWpGaD
Dronabinol—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000356	0.00194	CcSEcCtD
Dronabinol—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000355	0.00194	CcSEcCtD
Dronabinol—Rhinitis—Triamcinolone—atopic dermatitis	0.000355	0.00194	CcSEcCtD
Dronabinol—Rhinitis—Methylprednisolone—atopic dermatitis	0.000354	0.00193	CcSEcCtD
Dronabinol—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000353	0.00193	CcSEcCtD
Dronabinol—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000353	0.00193	CcSEcCtD
Dronabinol—Hallucination—Methylprednisolone—atopic dermatitis	0.000352	0.00192	CcSEcCtD
Dronabinol—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00035	0.00191	CcSEcCtD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00035	0.00784	CbGpPWpGaD
Dronabinol—Conjunctivitis—Betamethasone—atopic dermatitis	0.000348	0.0019	CcSEcCtD
Dronabinol—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000348	0.0019	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000343	0.00768	CbGpPWpGaD
Dronabinol—Immune system disorder—Hydrocortisone—atopic dermatitis	0.00034	0.00186	CcSEcCtD
Dronabinol—Rash—Mometasone—atopic dermatitis	0.00034	0.00185	CcSEcCtD
Dronabinol—Dermatitis—Mometasone—atopic dermatitis	0.000339	0.00185	CcSEcCtD
Dronabinol—Abdominal pain—Tacrolimus—atopic dermatitis	0.000339	0.00185	CcSEcCtD
Dronabinol—Headache—Mometasone—atopic dermatitis	0.000337	0.00184	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000335	0.00749	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CCR3—atopic dermatitis	0.000333	0.00745	CbGpPWpGaD
Dronabinol—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000329	0.00736	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL22—atopic dermatitis	0.000325	0.00728	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000321	0.00717	CbGpPWpGaD
Dronabinol—Hallucination—Dexamethasone—atopic dermatitis	0.00032	0.00175	CcSEcCtD
Dronabinol—Hallucination—Betamethasone—atopic dermatitis	0.00032	0.00175	CcSEcCtD
Dronabinol—CNR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.000319	0.00715	CbGpPWpGaD
Dronabinol—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000319	0.00174	CcSEcCtD
Dronabinol—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000316	0.00172	CcSEcCtD
Dronabinol—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000311	0.0017	CcSEcCtD
Dronabinol—Depression—Prednisone—atopic dermatitis	0.000311	0.0017	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000309	0.00692	CbGpPWpGaD
Dronabinol—Asthenia—Tacrolimus—atopic dermatitis	0.000308	0.00168	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000306	0.00685	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000306	0.00685	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000305	0.00682	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000304	0.00166	CcSEcCtD
Dronabinol—Pruritus—Tacrolimus—atopic dermatitis	0.000303	0.00166	CcSEcCtD
Dronabinol—Malaise—Prednisolone—atopic dermatitis	0.000302	0.00165	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000302	0.00674	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0003	0.00671	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—NPS—atopic dermatitis	0.000297	0.00664	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—TAC1—atopic dermatitis	0.000297	0.00664	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000297	0.00664	CbGpPWpGaD
Dronabinol—Malaise—Hydrocortisone—atopic dermatitis	0.000295	0.00161	CcSEcCtD
Dronabinol—Diarrhoea—Tacrolimus—atopic dermatitis	0.000293	0.0016	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.000291	0.00651	CbGpPWpGaD
Dronabinol—Convulsion—Prednisolone—atopic dermatitis	0.000291	0.00159	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—CCL27—atopic dermatitis	0.00029	0.00649	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000286	0.00156	CcSEcCtD
Dronabinol—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000286	0.00156	CcSEcCtD
Dronabinol—Convulsion—Hydrocortisone—atopic dermatitis	0.000284	0.00155	CcSEcCtD
Dronabinol—Dizziness—Tacrolimus—atopic dermatitis	0.000283	0.00155	CcSEcCtD
Dronabinol—Discomfort—Prednisolone—atopic dermatitis	0.000282	0.00154	CcSEcCtD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00028	0.00626	CbGpPWpGaD
Dronabinol—Myalgia—Hydrocortisone—atopic dermatitis	0.000279	0.00152	CcSEcCtD
Dronabinol—Hallucination—Prednisone—atopic dermatitis	0.000279	0.00152	CcSEcCtD
Dronabinol—Malaise—Triamcinolone—atopic dermatitis	0.000278	0.00152	CcSEcCtD
Dronabinol—Anxiety—Hydrocortisone—atopic dermatitis	0.000278	0.00152	CcSEcCtD
Dronabinol—Malaise—Methylprednisolone—atopic dermatitis	0.000278	0.00151	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000277	0.00151	CcSEcCtD
Dronabinol—Discomfort—Hydrocortisone—atopic dermatitis	0.000276	0.0015	CcSEcCtD
Dronabinol—Rash—Tacrolimus—atopic dermatitis	0.00027	0.00147	CcSEcCtD
Dronabinol—Dermatitis—Tacrolimus—atopic dermatitis	0.00027	0.00147	CcSEcCtD
Dronabinol—Cough—Triamcinolone—atopic dermatitis	0.000269	0.00147	CcSEcCtD
Dronabinol—Headache—Tacrolimus—atopic dermatitis	0.000268	0.00147	CcSEcCtD
Dronabinol—Convulsion—Triamcinolone—atopic dermatitis	0.000267	0.00146	CcSEcCtD
Dronabinol—Tachycardia—Prednisolone—atopic dermatitis	0.000267	0.00146	CcSEcCtD
Dronabinol—Convulsion—Methylprednisolone—atopic dermatitis	0.000267	0.00146	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000266	0.00595	CbGpPWpGaD
Dronabinol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000265	0.00144	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000263	0.00587	CbGpPWpGaD
Dronabinol—Myalgia—Triamcinolone—atopic dermatitis	0.000263	0.00143	CcSEcCtD
Dronabinol—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000262	0.00143	CcSEcCtD
Dronabinol—Myalgia—Methylprednisolone—atopic dermatitis	0.000262	0.00143	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCR3—atopic dermatitis	0.000261	0.00585	CbGpPWpGaD
Dronabinol—Anxiety—Methylprednisolone—atopic dermatitis	0.000261	0.00143	CcSEcCtD
Dronabinol—Tachycardia—Hydrocortisone—atopic dermatitis	0.000261	0.00142	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00026	0.00142	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—CCL17—atopic dermatitis	0.00026	0.00582	CbGpPWpGaD
Dronabinol—Flushing—Prednisone—atopic dermatitis	0.00026	0.00142	CcSEcCtD
Dronabinol—Skin disorder—Hydrocortisone—atopic dermatitis	0.00026	0.00142	CcSEcCtD
Dronabinol—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00026	0.00142	CcSEcCtD
Dronabinol—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00026	0.00142	CcSEcCtD
Dronabinol—Discomfort—Triamcinolone—atopic dermatitis	0.000259	0.00142	CcSEcCtD
Dronabinol—Discomfort—Methylprednisolone—atopic dermatitis	0.000259	0.00141	CcSEcCtD
Dronabinol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000258	0.00141	CcSEcCtD
Dronabinol—Dry mouth—Triamcinolone—atopic dermatitis	0.000257	0.0014	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—CCL22—atopic dermatitis	0.000255	0.00571	CbGpPWpGaD
Dronabinol—Anorexia—Hydrocortisone—atopic dermatitis	0.000255	0.00139	CcSEcCtD
Dronabinol—Confusional state—Methylprednisolone—atopic dermatitis	0.000253	0.00138	CcSEcCtD
Dronabinol—Immune system disorder—Prednisone—atopic dermatitis	0.000253	0.00138	CcSEcCtD
Dronabinol—Malaise—Betamethasone—atopic dermatitis	0.000252	0.00138	CcSEcCtD
Dronabinol—Malaise—Dexamethasone—atopic dermatitis	0.000252	0.00138	CcSEcCtD
Dronabinol—CNR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000251	0.00561	CbGpPWpGaD
Dronabinol—Hypotension—Hydrocortisone—atopic dermatitis	0.00025	0.00136	CcSEcCtD
Dronabinol—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000246	0.00134	CcSEcCtD
Dronabinol—Tachycardia—Triamcinolone—atopic dermatitis	0.000246	0.00134	CcSEcCtD
Dronabinol—Tachycardia—Methylprednisolone—atopic dermatitis	0.000245	0.00134	CcSEcCtD
Dronabinol—Skin disorder—Methylprednisolone—atopic dermatitis	0.000244	0.00133	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000244	0.00133	CcSEcCtD
Dronabinol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000243	0.00133	CcSEcCtD
Dronabinol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000243	0.00133	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000243	0.00543	CbGpPWpGaD
Dronabinol—Convulsion—Dexamethasone—atopic dermatitis	0.000242	0.00132	CcSEcCtD
Dronabinol—Convulsion—Betamethasone—atopic dermatitis	0.000242	0.00132	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00024	0.00536	CbGpPWpGaD
Dronabinol—Myalgia—Dexamethasone—atopic dermatitis	0.000238	0.0013	CcSEcCtD
Dronabinol—Myalgia—Betamethasone—atopic dermatitis	0.000238	0.0013	CcSEcCtD
Dronabinol—Anxiety—Dexamethasone—atopic dermatitis	0.000237	0.0013	CcSEcCtD
Dronabinol—Anxiety—Betamethasone—atopic dermatitis	0.000237	0.0013	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000237	0.00529	CbGpPWpGaD
Dronabinol—Discomfort—Dexamethasone—atopic dermatitis	0.000235	0.00128	CcSEcCtD
Dronabinol—Discomfort—Betamethasone—atopic dermatitis	0.000235	0.00128	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000235	0.00527	CbGpPWpGaD
Dronabinol—Hypotension—Methylprednisolone—atopic dermatitis	0.000235	0.00128	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—TAC1—atopic dermatitis	0.000233	0.00521	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—NPS—atopic dermatitis	0.000233	0.00521	CbGpPWpGaD
Dronabinol—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000232	0.00127	CcSEcCtD
Dronabinol—Fatigue—Hydrocortisone—atopic dermatitis	0.000231	0.00126	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000229	0.00125	CcSEcCtD
Dronabinol—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000229	0.00512	CbGpPWpGaD
Dronabinol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000229	0.00125	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000229	0.00511	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL27—atopic dermatitis	0.000228	0.00509	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Prednisone—atopic dermatitis	0.000226	0.00123	CcSEcCtD
Dronabinol—Feeling abnormal—Prednisolone—atopic dermatitis	0.000226	0.00123	CcSEcCtD
Dronabinol—Nervous system disorder—Betamethasone—atopic dermatitis	0.000224	0.00122	CcSEcCtD
Dronabinol—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000224	0.00122	CcSEcCtD
Dronabinol—Tachycardia—Betamethasone—atopic dermatitis	0.000223	0.00122	CcSEcCtD
Dronabinol—Tachycardia—Dexamethasone—atopic dermatitis	0.000223	0.00122	CcSEcCtD
Dronabinol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000221	0.00121	CcSEcCtD
Dronabinol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000221	0.00121	CcSEcCtD
Dronabinol—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.00022	0.0012	CcSEcCtD
Dronabinol—Malaise—Prednisone—atopic dermatitis	0.00022	0.0012	CcSEcCtD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00022	0.00491	CbGpPWpGaD
Dronabinol—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000219	0.00119	CcSEcCtD
Dronabinol—Anorexia—Betamethasone—atopic dermatitis	0.000218	0.00119	CcSEcCtD
Dronabinol—Anorexia—Dexamethasone—atopic dermatitis	0.000218	0.00119	CcSEcCtD
Dronabinol—Fatigue—Triamcinolone—atopic dermatitis	0.000217	0.00118	CcSEcCtD
Dronabinol—Fatigue—Methylprednisolone—atopic dermatitis	0.000217	0.00118	CcSEcCtD
Dronabinol—Hypotension—Dexamethasone—atopic dermatitis	0.000213	0.00117	CcSEcCtD
Dronabinol—Hypotension—Betamethasone—atopic dermatitis	0.000213	0.00117	CcSEcCtD
Dronabinol—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000211	0.00115	CcSEcCtD
Dronabinol—Convulsion—Prednisone—atopic dermatitis	0.000211	0.00115	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—CCL11—atopic dermatitis	0.00021	0.00469	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000209	0.00467	CbGpPWpGaD
Dronabinol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000208	0.00114	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000208	0.00114	CcSEcCtD
Dronabinol—Myalgia—Prednisone—atopic dermatitis	0.000208	0.00113	CcSEcCtD
Dronabinol—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000207	0.00113	CcSEcCtD
Dronabinol—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000207	0.00113	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—FCER2—atopic dermatitis	0.000207	0.00463	CbGpPWpGaD
Dronabinol—Anxiety—Prednisone—atopic dermatitis	0.000207	0.00113	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000206	0.00112	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000205	0.00112	CcSEcCtD
Dronabinol—Discomfort—Prednisone—atopic dermatitis	0.000205	0.00112	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—CCL17—atopic dermatitis	0.000204	0.00457	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CCL5—atopic dermatitis	0.000203	0.00453	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000202	0.00452	CbGpPWpGaD
Dronabinol—Hypersensitivity—Prednisolone—atopic dermatitis	0.000202	0.0011	CcSEcCtD
Dronabinol—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000199	0.00108	CcSEcCtD
Dronabinol—Decreased appetite—Betamethasone—atopic dermatitis	0.000199	0.00108	CcSEcCtD
Dronabinol—Decreased appetite—Dexamethasone—atopic dermatitis	0.000199	0.00108	CcSEcCtD
Dronabinol—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000197	0.00108	CcSEcCtD
Dronabinol—Fatigue—Betamethasone—atopic dermatitis	0.000197	0.00107	CcSEcCtD
Dronabinol—Fatigue—Dexamethasone—atopic dermatitis	0.000197	0.00107	CcSEcCtD
Dronabinol—Nervous system disorder—Prednisone—atopic dermatitis	0.000195	0.00106	CcSEcCtD
Dronabinol—Tachycardia—Prednisone—atopic dermatitis	0.000194	0.00106	CcSEcCtD
Dronabinol—Skin disorder—Prednisone—atopic dermatitis	0.000193	0.00105	CcSEcCtD
Dronabinol—Hyperhidrosis—Prednisone—atopic dermatitis	0.000192	0.00105	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—CCL22—atopic dermatitis	0.000192	0.0043	CbGpPWpGaD
Dronabinol—Asthenia—Hydrocortisone—atopic dermatitis	0.000192	0.00105	CcSEcCtD
Dronabinol—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000191	0.00428	CbGpPWpGaD
Dronabinol—Anorexia—Prednisone—atopic dermatitis	0.00019	0.00103	CcSEcCtD
Dronabinol—Pruritus—Hydrocortisone—atopic dermatitis	0.000189	0.00103	CcSEcCtD
Dronabinol—CNR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000188	0.00421	CbGpPWpGaD
Dronabinol—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000188	0.00103	CcSEcCtD
Dronabinol—Feeling abnormal—Betamethasone—atopic dermatitis	0.000188	0.00103	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000188	0.00421	CbGpPWpGaD
Dronabinol—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000187	0.00102	CcSEcCtD
Dronabinol—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000187	0.00102	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000186	0.00416	CbGpPWpGaD
Dronabinol—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000185	0.00101	CcSEcCtD
Dronabinol—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000185	0.00101	CcSEcCtD
Dronabinol—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000185	0.00413	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000185	0.00413	CbGpPWpGaD
Dronabinol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000184	0.00412	CbGpPWpGaD
Dronabinol—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000183	0.000998	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000183	0.00408	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000182	0.00408	CbGpPWpGaD
Dronabinol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000181	0.000989	CcSEcCtD
Dronabinol—Dizziness—Prednisolone—atopic dermatitis	0.000181	0.000988	CcSEcCtD
Dronabinol—Asthenia—Triamcinolone—atopic dermatitis	0.000181	0.000986	CcSEcCtD
Dronabinol—Abdominal pain—Betamethasone—atopic dermatitis	0.000181	0.000986	CcSEcCtD
Dronabinol—Abdominal pain—Dexamethasone—atopic dermatitis	0.000181	0.000986	CcSEcCtD
Dronabinol—Asthenia—Methylprednisolone—atopic dermatitis	0.00018	0.000984	CcSEcCtD
Dronabinol—Pruritus—Triamcinolone—atopic dermatitis	0.000178	0.000972	CcSEcCtD
Dronabinol—Pruritus—Methylprednisolone—atopic dermatitis	0.000178	0.00097	CcSEcCtD
Dronabinol—Dizziness—Hydrocortisone—atopic dermatitis	0.000177	0.000965	CcSEcCtD
Dronabinol—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000173	0.00387	CbGpPWpGaD
Dronabinol—Decreased appetite—Prednisone—atopic dermatitis	0.000173	0.000944	CcSEcCtD
Dronabinol—Rash—Prednisolone—atopic dermatitis	0.000173	0.000942	CcSEcCtD
Dronabinol—Dermatitis—Prednisolone—atopic dermatitis	0.000172	0.000941	CcSEcCtD
Dronabinol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000172	0.00385	CbGpPWpGaD
Dronabinol—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000172	0.000938	CcSEcCtD
Dronabinol—Fatigue—Prednisone—atopic dermatitis	0.000172	0.000936	CcSEcCtD
Dronabinol—Headache—Prednisolone—atopic dermatitis	0.000171	0.000936	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—CCL27—atopic dermatitis	0.000171	0.00383	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000171	0.00382	CbGpPWpGaD
Dronabinol—Rash—Hydrocortisone—atopic dermatitis	0.000169	0.00092	CcSEcCtD
Dronabinol—Dermatitis—Hydrocortisone—atopic dermatitis	0.000168	0.000919	CcSEcCtD
Dronabinol—CNR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000168	0.00375	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000168	0.00375	CbGpPWpGaD
Dronabinol—Headache—Hydrocortisone—atopic dermatitis	0.000167	0.000914	CcSEcCtD
Dronabinol—Dizziness—Triamcinolone—atopic dermatitis	0.000166	0.000909	CcSEcCtD
Dronabinol—Dizziness—Methylprednisolone—atopic dermatitis	0.000166	0.000907	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000165	0.00368	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000165	0.00368	CbGpPWpGaD
Dronabinol—Feeling abnormal—Prednisone—atopic dermatitis	0.000164	0.000895	CcSEcCtD
Dronabinol—Asthenia—Dexamethasone—atopic dermatitis	0.000164	0.000895	CcSEcCtD
Dronabinol—Asthenia—Betamethasone—atopic dermatitis	0.000164	0.000895	CcSEcCtD
Dronabinol—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000163	0.000888	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—FCER2—atopic dermatitis	0.000162	0.00363	CbGpPWpGaD
Dronabinol—Pruritus—Dexamethasone—atopic dermatitis	0.000162	0.000882	CcSEcCtD
Dronabinol—Pruritus—Betamethasone—atopic dermatitis	0.000162	0.000882	CcSEcCtD
Dronabinol—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000159	0.00356	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000159	0.00356	CbGpPWpGaD
Dronabinol—Rash—Triamcinolone—atopic dermatitis	0.000159	0.000866	CcSEcCtD
Dronabinol—Dermatitis—Triamcinolone—atopic dermatitis	0.000159	0.000866	CcSEcCtD
Dronabinol—Rash—Methylprednisolone—atopic dermatitis	0.000158	0.000864	CcSEcCtD
Dronabinol—Dermatitis—Methylprednisolone—atopic dermatitis	0.000158	0.000864	CcSEcCtD
Dronabinol—Headache—Triamcinolone—atopic dermatitis	0.000158	0.000861	CcSEcCtD
Dronabinol—Headache—Methylprednisolone—atopic dermatitis	0.000157	0.000859	CcSEcCtD
Dronabinol—Abdominal pain—Prednisone—atopic dermatitis	0.000157	0.000858	CcSEcCtD
Dronabinol—Diarrhoea—Betamethasone—atopic dermatitis	0.000156	0.000853	CcSEcCtD
Dronabinol—Diarrhoea—Dexamethasone—atopic dermatitis	0.000156	0.000853	CcSEcCtD
Dronabinol—CNR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000156	0.00349	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL17—atopic dermatitis	0.000154	0.00344	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—NPS—atopic dermatitis	0.000152	0.00341	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000152	0.00341	CbGpPWpGaD
Dronabinol—Dizziness—Betamethasone—atopic dermatitis	0.000151	0.000824	CcSEcCtD
Dronabinol—Dizziness—Dexamethasone—atopic dermatitis	0.000151	0.000824	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—CCL22—atopic dermatitis	0.000151	0.00338	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000149	0.00334	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000148	0.00331	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000148	0.00331	CbGpPWpGaD
Dronabinol—Hypersensitivity—Prednisone—atopic dermatitis	0.000147	0.0008	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000145	0.00324	CbGpPWpGaD
Dronabinol—Rash—Betamethasone—atopic dermatitis	0.000144	0.000786	CcSEcCtD
Dronabinol—Rash—Dexamethasone—atopic dermatitis	0.000144	0.000786	CcSEcCtD
Dronabinol—Dermatitis—Betamethasone—atopic dermatitis	0.000144	0.000785	CcSEcCtD
Dronabinol—Dermatitis—Dexamethasone—atopic dermatitis	0.000144	0.000785	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000143	0.0032	CbGpPWpGaD
Dronabinol—Headache—Betamethasone—atopic dermatitis	0.000143	0.000781	CcSEcCtD
Dronabinol—Headache—Dexamethasone—atopic dermatitis	0.000143	0.000781	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000143	0.0032	CbGpPWpGaD
Dronabinol—Asthenia—Prednisone—atopic dermatitis	0.000143	0.000779	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—IL5—atopic dermatitis	0.000142	0.00317	CbGpPWpGaD
Dronabinol—Pruritus—Prednisone—atopic dermatitis	0.000141	0.000768	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000137	0.00306	CbGpPWpGaD
Dronabinol—Diarrhoea—Prednisone—atopic dermatitis	0.000136	0.000743	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—CCL27—atopic dermatitis	0.000134	0.00301	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000134	0.003	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000133	0.00298	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000132	0.00295	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000132	0.00295	CbGpPWpGaD
Dronabinol—Dizziness—Prednisone—atopic dermatitis	0.000132	0.000718	CcSEcCtD
Dronabinol—CNR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000129	0.00289	CbGpPWpGaD
Dronabinol—Rash—Prednisone—atopic dermatitis	0.000125	0.000685	CcSEcCtD
Dronabinol—Dermatitis—Prednisone—atopic dermatitis	0.000125	0.000684	CcSEcCtD
Dronabinol—Headache—Prednisone—atopic dermatitis	0.000125	0.00068	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—CMA1—atopic dermatitis	0.000124	0.00277	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL11—atopic dermatitis	0.000124	0.00277	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000123	0.00275	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000122	0.00274	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000121	0.0027	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL17—atopic dermatitis	0.000121	0.0027	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—TAC1—atopic dermatitis	0.00012	0.00268	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—NPS—atopic dermatitis	0.00012	0.00268	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000117	0.00262	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—STAT6—atopic dermatitis	0.000116	0.00261	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000115	0.00256	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000114	0.00254	CbGpPWpGaD
Dronabinol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000114	0.00254	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL5—atopic dermatitis	0.000111	0.00249	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.00011	0.00247	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.00011	0.00245	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000109	0.00244	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL10—atopic dermatitis	0.000108	0.00242	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000108	0.00241	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000106	0.00237	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL4—atopic dermatitis	0.000105	0.00236	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000104	0.00234	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000104	0.00233	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000104	0.00232	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000103	0.00231	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000103	0.00231	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCR3—atopic dermatitis	0.000101	0.00226	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL11—atopic dermatitis	9.72e-05	0.00218	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CMA1—atopic dermatitis	9.72e-05	0.00218	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCL10—atopic dermatitis	9.48e-05	0.00212	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCR5—atopic dermatitis	9.37e-05	0.0021	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	9.25e-05	0.00207	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—STAT6—atopic dermatitis	9.14e-05	0.00204	CbGpPWpGaD
Dronabinol—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	9.02e-05	0.00202	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TAC1—atopic dermatitis	9e-05	0.00201	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—NPS—atopic dermatitis	9e-05	0.00201	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCL5—atopic dermatitis	8.99e-05	0.00201	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCR3—atopic dermatitis	8.83e-05	0.00198	CbGpPWpGaD
Dronabinol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	8.82e-05	0.00197	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CXCL8—atopic dermatitis	8.66e-05	0.00194	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL5—atopic dermatitis	8.37e-05	0.00187	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL5—atopic dermatitis	8.16e-05	0.00183	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCR5—atopic dermatitis	8.1e-05	0.00181	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	7.95e-05	0.00178	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	7.95e-05	0.00178	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR3—atopic dermatitis	7.93e-05	0.00177	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	7.49e-05	0.00167	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.46e-05	0.00167	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCR5—atopic dermatitis	7.35e-05	0.00164	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCL10—atopic dermatitis	7.14e-05	0.0016	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NPS—atopic dermatitis	7.06e-05	0.00158	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TAC1—atopic dermatitis	7.06e-05	0.00158	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	7.02e-05	0.00157	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCR3—atopic dermatitis	6.93e-05	0.00155	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	6.72e-05	0.0015	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL5—atopic dermatitis	6.57e-05	0.00147	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	6.36e-05	0.00142	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CXCL8—atopic dermatitis	6.24e-05	0.0014	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL5—atopic dermatitis	6.14e-05	0.00137	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.11e-05	0.00137	CbGpPWpGaD
Dronabinol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	6.08e-05	0.00136	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—IL2—atopic dermatitis	5.96e-05	0.00133	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	5.92e-05	0.00132	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—NGF—atopic dermatitis	5.69e-05	0.00127	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	5.68e-05	0.00127	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CXCL8—atopic dermatitis	5.66e-05	0.00127	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL2—atopic dermatitis	5.66e-05	0.00127	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCL10—atopic dermatitis	5.6e-05	0.00125	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	5.6e-05	0.00125	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.57e-05	0.00125	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCR5—atopic dermatitis	5.53e-05	0.00124	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	5.42e-05	0.00121	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL2—atopic dermatitis	5.41e-05	0.00121	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GLB1—atopic dermatitis	4.91e-05	0.0011	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.89e-05	0.00109	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL5—atopic dermatitis	4.82e-05	0.00108	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GLB1—atopic dermatitis	4.72e-05	0.00105	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ADSL—atopic dermatitis	4.71e-05	0.00105	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—NFKBIA—atopic dermatitis	4.69e-05	0.00105	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—IL2—atopic dermatitis	4.68e-05	0.00105	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ADSL—atopic dermatitis	4.52e-05	0.00101	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NGF—atopic dermatitis	4.46e-05	0.000999	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GLB1—atopic dermatitis	4.46e-05	0.000998	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCL8—atopic dermatitis	4.44e-05	0.000994	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR5—atopic dermatitis	4.34e-05	0.000971	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ADSL—atopic dermatitis	4.28e-05	0.000956	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL2—atopic dermatitis	4.25e-05	0.00095	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—TNF—atopic dermatitis	4.12e-05	0.000922	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.1e-05	0.000916	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.8e-05	0.000849	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.69e-05	0.000826	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NFKBIA—atopic dermatitis	3.68e-05	0.000824	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.44e-05	0.000769	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.4e-05	0.000761	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCL8—atopic dermatitis	3.35e-05	0.000748	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GLB1—atopic dermatitis	3.32e-05	0.000743	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL2—atopic dermatitis	3.2e-05	0.000715	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ADSL—atopic dermatitis	3.19e-05	0.000713	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL6—atopic dermatitis	3.18e-05	0.000712	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MAPK8—atopic dermatitis	2.94e-05	0.000658	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GLB1—atopic dermatitis	2.72e-05	0.000608	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GLB1—atopic dermatitis	2.65e-05	0.000594	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCL8—atopic dermatitis	2.63e-05	0.000587	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ADSL—atopic dermatitis	2.61e-05	0.000583	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.57e-05	0.000575	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ADSL—atopic dermatitis	2.54e-05	0.000569	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL2—atopic dermatitis	2.51e-05	0.000561	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL6—atopic dermatitis	2.5e-05	0.000559	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.48e-05	0.000555	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.42e-05	0.000542	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.38e-05	0.000532	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MAPK8—atopic dermatitis	2.31e-05	0.000517	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.03e-05	0.000455	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.98e-05	0.000443	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL6—atopic dermatitis	1.88e-05	0.00042	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.84e-05	0.000411	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.81e-05	0.000404	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.64e-05	0.000366	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PPARA—atopic dermatitis	1.59e-05	0.000356	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.57e-05	0.000351	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PPARA—atopic dermatitis	1.53e-05	0.000342	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL6—atopic dermatitis	1.47e-05	0.00033	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PPARA—atopic dermatitis	1.45e-05	0.000324	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PPARA—atopic dermatitis	1.08e-05	0.000241	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PPARA—atopic dermatitis	8.82e-06	0.000197	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PPARA—atopic dermatitis	8.61e-06	0.000193	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PPARA—atopic dermatitis	8.05e-06	0.00018	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PPARA—atopic dermatitis	5.31e-06	0.000119	CbGpPWpGaD
